Information  X 
Enter a valid email address

Microsaic Systems (MSYS)

  Print      Mail a friend

Wednesday 13 June, 2018

Microsaic Systems

Distribution Agreement with Omicron Research Ltd.

RNS Number : 1765R
Microsaic Systems plc
13 June 2018

13 June 2018

Microsaic Systems plc


("Microsaic" or the "Company")


Distribution Agreement with Omicron Research Ltd.


Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, is pleased to announce that it has signed an agreement with Omicron Research Ltd. ("Omicron") to distribute Microsaic's 4500 MiD® MS detector via Omicron's distribution network in the United Kingdom.


Omicron is a UK distributor for a range of scientific instrumentation specialising in Dissolution, Chromatography and Spectroscopy, working in partnership with some of the largest scientific instrument manufacturers in the marketplace today.


Glenn Tracey, CEO of Microsaic, commented, "I am delighted to partner with one of the leading distributors of CAMAG-branded Thin Layer Chromatography ("TLC") equipment in the UK.


"TLC is a growing application area, enabling fast and simple analyses in a variety of industries, including natural products, pharmaceuticals, food and environmental. The addition of our point of need MS provides rapid compound elucidation, allowing the scientist method flexibility and simplicity with rapid diagnostic.


"Omicron is a well-established distributor of scientific instrumentation and has a strong reputation for its applications expertise and customer service.


"CAMAG is a world leader in planar chromatography. Since 1961, CAMAG has been dedicated to the development and manufacturing of instruments, software and consumables for all steps of the TLC or High-Performance Thin Layer Chromatography ("HPTLC") procedure.


"Wherever complex substance mixtures are analysed (e.g. herbal, environmental or forensic samples), TLC/HPTLC often is an excellent alternative to Gas Chromatography ("GC") and High-Performance Liquid Chromatography ("HPLC"). Moreover, it has proven value as a solid quantitative analysis technique in quality assurance of food, pharmaceuticals and other industrial products.

"Based in Muttenz, Basel, their products have an excellent reputation throughout the world."


Sam Stringer, Commercial Director of Omicron Research Ltd, added "The addition of Microsaic's innovative 4500 MiD MS detector to our product portfolio will enable Omicron to provide an exciting new opportunity to expand the analytical flexibility of TLC and HPTLC. Demand on our customers in the field of planar chromatography for further structural elucidation of their components is high, and Microsaic can provide an elegant, complementary solution to help facilitate this. Building on existing collaborations, we believe this combination of expertise and technology will be highly successful in the UK marketplace.






Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD

+44 (0) 1483 751 577


N+1 Singer (Nominated Adviser & Broker)

Shaun Dobson

Liz Yong



+44 (0)20 7496 3000

IFC Advisory Ltd (Financial PR)

Graham Herring

Heather Armstrong

Florence Chandler

+44 (0)20 3934 6630



About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.


Microsaic's core product, the 4500 MiD®, is a robust and compact MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to  




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t